This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,359.88 firm fixed-price delivery order is for the supply of 4,566,734,895 units of the ENGERIX-B 20 MCG/ML SYRNML vaccine. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's extensive capabilities in supplying critical medical commodities, including specialty medications, generic drugs, vaccines, and other medical supplies, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/17/25, 9:49 AM